Edition:
United Kingdom

BeyondSpring Inc (BYSI.OQ)

BYSI.OQ on NASDAQ Stock Exchange Capital Market

19.50USD
16 Aug 2018
Change (% chg)

$0.19 (+0.98%)
Prev Close
$19.31
Open
$19.75
Day's High
$20.08
Day's Low
$19.50
Volume
1,347
Avg. Vol
4,094
52-wk High
$41.96
52-wk Low
$19.31

Chart for

About

BeyondSpring Inc. is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $892.10
Shares Outstanding(Mil.): 22.84
Dividend: --
Yield (%): --

Financials

  BYSI.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -3.97 -- --
ROI: -268.89 1.78 14.61
ROE: -260.45 3.28 16.33

BRIEF-BeyondSpring Says Richard Brand Resigned As CFO

* BEYONDSPRING SAYS RICHARD A. BRAND RESIGNED AS CHIEF FINANCIAL OFFICER OF CO EFFECTIVE AS OF FEBRUARY 20, 2018 - SEC FILING

21 Feb 2018

Earnings vs. Estimates